Overview

Kineret in the Treatment of Rheumatoid Arthritis

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
0
Participant gender:
All
Summary
Objective of the study is to gain knowledge about the administration of Kineret in patients with rheumatoid arthritis in the daily routine treatment and not in controlled trials. In the current survey, the investigation of the response rate of Kineret regarding the date of onset of action, the efficacy, as well as the tolerability and safety are of particular interest.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Swedish Orphan Biovitrum
Treatments:
Interleukin 1 Receptor Antagonist Protein
Criteria
Inclusion Criteria:

- Informed consent by the patient

- Rheumatoid arthritis

- Previous methotrexate therapy with inadequate response

Exclusion Criteria:

- Pregnancy